AVISE® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout
October 24, 2019 08:20 ET
|
Exagen, Inc.
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate...
Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America
October 21, 2019 08:15 ET
|
Exagen, Inc.
SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 23, 2019 13:36 ET
|
Exagen Inc.
SAN DIEGO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. Announces Pricing of Initial Public Offering
September 18, 2019 19:14 ET
|
Exagen Inc.
San Diego, CA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
August 19, 2019 08:57 ET
|
Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
April 24, 2019 09:55 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019
February 11, 2019 09:58 ET
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health...
Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference
November 13, 2018 09:30 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that it will present at the Piper Jaffray 30th Annual...
Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
October 30, 2018 10:30 ET
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca,...
Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus
October 12, 2018 10:01 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, announced today that it will be updating the popular AVISE® SLE Monitor...